tiprankstipranks
Madrigal Pharmaceuticals price target raised to $441 from $411 at UBS
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $441 from $411 at UBS
20d ago
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch
20d ago
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
21d ago
3 Best Stocks to Buy Now, 10/23/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 10/23/2024, According to Top Analysts 
29d ago
Madrigal Pharmaceuticals completes enrollment of study of Resmetirom
Premium
The Fly
Madrigal Pharmaceuticals completes enrollment of study of Resmetirom
1M ago
Madrigal Pharmaceuticals management to meet with JMP Securities
Premium
The Fly
Madrigal Pharmaceuticals management to meet with JMP Securities
2M ago
Madrigal Pharmaceuticals price target lowered to $371 from $382 at Citi
PremiumThe FlyMadrigal Pharmaceuticals price target lowered to $371 from $382 at Citi
4M ago
Madrigal Pharmaceuticals reports Q2 EPS ($7.10), consensus ($7.52)
Premium
The Fly
Madrigal Pharmaceuticals reports Q2 EPS ($7.10), consensus ($7.52)
4M ago
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100